Introduced
by
To revise the definition of life science in the Michigan strategic fund act to include umbilical cord-blood stem cell research, which would qualify particular firms engaged in this activity that are selected by government committees for government subsidies.
Referred to the Committee on Health Policy
Reported without amendment
Without amendment and with the recommendation that the bill pass.
Passed in the House 106 to 0 (details)
Referred to the Committee on Health Policy
Reported without amendment
With the recommendation that the bill pass.
Passed in the Senate 38 to 0 (details)
To revise the definition of life science in the Michigan strategic fund act to include umbilical cord-blood stem cell research, which would qualify particular firms engaged in this activity that are selected by government committees for government subsidies.
